Original Research

Published on 20 Oct 2022

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma

in Cancer Immunity and Immunotherapy

Tiantian Liu
Jianni Qi
Hao Wu
Le Wang
Lihui Zhu
Chengyong Qin
Jiao Zhang
Qiang Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.993503

1,676 views
1 citation

Original Research

Published on 20 Oct 2022

SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer

in Cancer Immunity and Immunotherapy

Ying-Ying Zhao
Qian-Ming Xiang
Jia-Li Chen
Li Zhang
Wei-Long Zheng
Di Ke
Rong-Shu Shi
Kong-Wu Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.990247

2,285 views
3 citations

Editorial

Published on 18 Oct 2022

Editorial: Gastrointestinal cancer immune response and immune related adverse effects

in Cancer Immunity and Immunotherapy

Ti Wen
Yanhong Deng
Bo Qin

Frontiers in Oncology

doi 10.3389/fonc.2022.1034890

838 views

Systematic Review

Published on 18 Oct 2022

Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis

in Cancer Immunity and Immunotherapy

Handai Xia
Wengang Zhang
Yuqing Zhang
Xiaoling Shang
Yanguo Liu
Xiuwen Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.978069

5,924 views
22 citations

Perspective

Published on 18 Oct 2022

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response

in Cancer Immunity and Immunotherapy

Maria Tagliamonte
Luigi Buonaguro

Frontiers in Oncology

doi 10.3389/fonc.2022.1009247

2,154 views
6 citations

Review

Published on 13 Oct 2022

Targeting FGL2 in glioma immunosuppression and malignant progression

in Cancer Immunity and Immunotherapy

Xiaoyu Ma
Hongtao Zhu
Lidong Cheng
Xin Chen
Kai Shu
Suojun Zhang

Frontiers in Oncology

doi 10.3389/fonc.2022.1004700

3,514 views
7 citations

Mini Review

Published on 13 Oct 2022

Inflammatory microenvironment in classical Hodgkin’s lymphoma with special stress on mast cells

in Cancer Immunity and Immunotherapy

Domenico Ribatti
Roberto Tamma
Tiziana Annese
Giuseppe Ingravallo
Giorgina Specchia

Frontiers in Oncology

doi 10.3389/fonc.2022.964573

1,697 views
5 citations

Original Research

Published on 13 Oct 2022

Peripheral absolute eosinophil count identifies the risk of serious immune-related adverse events in non-small cell lung cancer

in Cancer Immunity and Immunotherapy

Yan Wu
Dapeng Li
Mengyao Wu
Ying Yang
Meng Shen
Kai Chen

Frontiers in Oncology

doi 10.3389/fonc.2022.1004663

1,575 views
3 citations

Review

Published on 12 Oct 2022

The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

in Cancer Immunity and Immunotherapy

Shanna Qian
Zhong Wei
Wanting Yang
Jinling Huang
Yinfeng Yang
Jinghui Wang

Frontiers in Oncology

doi 10.3389/fonc.2022.985363

45,583 views
277 citations

Original Research

Published on 12 Oct 2022

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

in Cancer Immunity and Immunotherapy

Lanlan Zhou
Nanzhou Yu
Tongjuan Li
Hongyan Ji
Lijun Jiang
Di Wang
Bin Xu
Xiaoxi Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.912689

1,699 views

Original Research

Published on 11 Oct 2022

The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer

in Cancer Immunity and Immunotherapy

Tobias Mohr
Anabel Zwick
Muriel Charlotte Hans
Isabelle Ariane Bley
Felix Leon Braun
Oybek Khalmurzaev
Vsevolod Borisovich Matveev
Philine Loertzer
Alexey Pryalukhin
Arndt Hartmann

Frontiers in Oncology

doi 10.3389/fonc.2022.891511

3,000 views
11 citations

Review

Published on 07 Oct 2022

Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential

in Cancer Immunity and Immunotherapy

Miao Luo
Xiaoyu Chen
Haojin Gao
Fan Yang
Jianxiang Chen
Yiting Qiao

Frontiers in Oncology

doi 10.3389/fonc.2022.980111

3,200 views
2 citations

Original Research

Published on 07 Oct 2022

SSX addiction in melanoma propagates tumor growth and metastasis

in Cancer Immunity and Immunotherapy

Sofie Traynor
Malene Laage Ebstrup
Odd Lilleng Gammelgaard
Behzad Mansoori
Mikkel Green Terp
Cecilie Rose Hauge Rein
Sofie Rattenborg
Christina Bøg Pedersen
Henrik Jørn Ditzel
Morten Frier Gjerstorff

Frontiers in Oncology

doi 10.3389/fonc.2022.998000

2,586 views
2 citations

Review

Published on 06 Oct 2022

Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer

in Cancer Immunity and Immunotherapy

Xiling Han
Wei-wei Chang
Xiaoping Xia

Frontiers in Oncology

doi 10.3389/fonc.2022.996495

3,803 views
9 citations

Review

Published on 06 Oct 2022

Vascular normalization and immunotherapy: Spawning a virtuous cycle

in Cancer Immunity and Immunotherapy

Kumara Swamy

Frontiers in Oncology

doi 10.3389/fonc.2022.1002957

3,430 views
10 citations

Review

Published on 03 Oct 2022

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination

in Cancer Immunity and Immunotherapy

Li-jie Zhang
Feng Chen
Xiao-ru Liang
Murugavel Ponnusamy
Hao Qin
Zhi-juan Lin

Frontiers in Oncology

doi 10.3389/fonc.2022.1008856

2,508 views
3 citations

Navigation group

Articles

Phosphogluconate dehydrogenase is a predictive biomarker for immunotherapy in hepatocellular carcinoma

SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer

Editorial: Gastrointestinal cancer immune response and immune related adverse effects

Liver metastases and the efficacy of immune checkpoint inhibitors in advanced lung cancer: A systematic review and meta-analysis

The impact of antigenic molecular mimicry on anti-cancer T-cell immune response

Targeting FGL2 in glioma immunosuppression and malignant progression

Inflammatory microenvironment in classical Hodgkin’s lymphoma with special stress on mast cells

Peripheral absolute eosinophil count identifies the risk of serious immune-related adverse events in non-small cell lung cancer

The role of BCL-2 family proteins in regulating apoptosis and cancer therapy

Clinical characteristics and prognosis of 16 relapsed/refractory B-cell malignancy patients with CAR T-cell-related hyperferritinaemia

The prominent role of the S100A8/S100A9-CD147 axis in the progression of penile cancer

Bacteria-mediated cancer therapy: A versatile bio-sapper with translational potential

SSX addiction in melanoma propagates tumor growth and metastasis

Immune checkpoint inhibitors in advanced and recurrent/metastatic cervical cancer

Vascular normalization and immunotherapy: Spawning a virtuous cycle

Crosstalk among long non-coding RNA, tumor-associated macrophages and small extracellular vesicles in tumorigenesis and dissemination